UPV spin off receives one million euros for the development of ACORYS, a medical device designed to improve the effectiveness and treatment of Atrial Fibrillation.

Corify Care, a spin off company of the Polytechnic University of Valencia (UPV), has obtained a one million euros grant from the Research and Development Centre for Industrial Technology Development (CDTI) of the Spanish Ministry of Science and Innovation.

This grant will be destinated for the development of ACORYS, a medical device that, using technology created by the Hospital General Universitario Gregorio Marañón and the UPV, enhances the effectiveness and non-invasive treatment of atrial fibrillation, a cardiac arrhythmia that affects more than 10 million people just across Europe.

Link to "El español"
Link to "Apunt" Video
Link to "Innospain"
Link to "La Sexta"
Link to "Cadena Ser"
Link to "News Medical"

Related posts
🚀 Corify Showcases ECGI’s Clinical Momentum at EHRA 2025

Corify Care had a strong presence at the European Heart Rhythm Association (EHRA) Congress 2025 in Vienna, with multiple scientific communications featuring...

Read More »
Corify Care Successfully Concludes DIDIMO Project: Advancing Personalized Cardiac Digital Twin Technology

Last September, Corify Care successfully concluded the DIDIMO Project (Personalized Cardiac Digital Twin to Improve the Development of Medical Devices and Cardiac...

Read More »
From an Idea to Reality: The Journey of Non-Invasive Cardiac Mapping 

Yesterday was a milestone moment for Corify Care. We returned to where it all began—Hospital Gregorio Marañón—to officially present our non-invasive cardiac...

Read More »